Viatris Inc Quick Ratio
The quick ratio is a stricter test of whether a company can pay the bills due within a year, counting only assets that are already cash or close to it. It is cash, marketable securities and receivables divided by current liabilities, shown as a multiple, with both amounts in the table. It is the current ratio with inventory and other assets that take longer to turn into cash removed, so it is never higher than the current ratio. A company that does not report one of the inputs has no point for that date rather than an estimated one. Quarterly points use quarter-end balances; annual points use fiscal-year-end balances.
- Viatris Inc quick ratio for the quarter ending 2026-06-30 was 0.63, a 18.00% increase year-over-year.
- Viatris Inc quick ratio for the quarter ending 2026-03-31 was 0.72, a 5.63% increase year-over-year.
- Viatris Inc quick ratio for the quarter ending 2025-12-31 was 0.62, a 9.85% decline year-over-year.
- Viatris Inc quick ratio for the quarter ending 2025-09-30 was 0.59, a 20.26% decline year-over-year.
- Viatris Inc quick ratio for fiscal 2025 was 0.62, a 9.85% decline from fiscal 2024.
- Viatris Inc quick ratio for fiscal 2024 was 0.68, a 13.45% increase from fiscal 2023.
- Viatris Inc quick ratio for fiscal 2023 was 0.6, a 19.80% decline from fiscal 2022.
- Viatris Inc quick ratio for fiscal 2022 was 0.75, a 49.59% increase from fiscal 2021.
- Available history
- 2019-12-31 to 2026-06-30
- Data captured
Historical Quick Ratio
Annual Quick Ratio
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |